Aberrant patterns of cellular communication in diabetes-induced embryopathy. I. Membrane signalling

Area of Science:

• Developmental Biology
• Endocrinology
• Cell Signaling

Background:

• Maternal hyperglycemia is a known risk factor for congenital malformations.
• The precise molecular mechanisms underlying diabetes-induced embryopathy are not fully understood.
• Membrane signaling pathways are critical for embryonic development.

Purpose of the Study:

• To investigate the role of membrane signaling in diabetes-induced embryopathy.
• To identify specific signaling molecules involved in hyperglycemia-related congenital malformations.
• To elucidate the cellular communication disruptions in diabetic embryopathy.

Main Methods:

• Sprague-Dawley rats were divided into control, diabetic with malformed offspring, and diabetic with normal offspring groups.
• Embryos were examined for morphological defects, and yolk sac cells were collected.
• Western blot analysis was used to assess the activity of ERK1/2, Raf-1, and JNK1/2 in yolk sac cells.

Main Results:

• Hyperglycemia was strongly correlated with congenital malformations.
• Increased activity of Jun-amino-terminal kinase (JNK1 and 2) was observed in embryos with embryopathy.
• Decreased activity of extracellular signal-regulated kinase (ERK1 and 2) was noted during hyperglycemia-induced embryopathy.

Conclusions:

• Poorly controlled maternal diabetes leads to embryopathy.
• Aberrant cellular communication, involving specific mitogen-activated protein kinases, mediates this process.
• Both macroscopic and microscopic membrane injury are implicated in diabetic embryopathy.